Aktuelles

Bilder

10 examples
Gene Drive - intervention in the "germline" of natural diversity
previous pauseresume next

Are GE plants with Bt toxins 20 times more toxic than previously known?

EFSA has for decades ignored crucial data from Monsanto
Friday, 11 December 2020

Data from Monsanto revealed that Bt proteins expressed in genetically engineered (GE) plants are significantly more toxic than natural Bt toxins. It is more than 30 years ago since, in 1990, Monsanto data first showed that if mixed with plant material from, e.g. soybeans, cotton and maize, toxicity could be up to 20 times higher. This is due to enzymes naturally present in the tissues of many crop plants. These findings were never taken into account by the European Food Safety Authority (EFSA). It seems as if EFSA simply overlooked the relevant publications.

EU close to approving New GE plants

EU Parliament strongly criticises current practice of risk assessment

2 December 2020 / Several new applications filed for the import of genetically engineered (GE) plants are about to be approved. Five new applications were filed by Bayer and Syngenta for maize and soybeans that are resistant to herbicides and/or produce insecticides. Some of these applications will be discussed tomorrow in a committee with experts from the EU Member States. If there is no qualified majority for or against an authorisation in this vote, the Commission may decide on the applications.

EFSA: Confusion about risks associated with New GE plants

Opinion of the EU authority considered insufficient and misleading

25 November 2020 / Testbiotech is extremely critical of a recent European Food Safety Agency (EFSA) opinion on the risks associated with plants derived from new genetic engineering (New GE). It considers the EFSA report on CRISPR & Co is both inadequate and misleading on the protection of health and the environment.

Sars-CoV-2 vaccine could be approved shortly

How safe are RNA technologies?

24 November 2020 / Sars-CoV-2 vaccines based on mRNA technology could be approved very soon. It would be the first mRNA vaccine to be approved for use in humans.

In biology, mRNA is a molecule used by living cells to translate DNA into proteins. The new mRNA-based vaccine is based on this principle; mRNA molecules that can be translated into a viral surface protein are produced in the laboratory and then injected. The aim is that the cells produce specific proteins which can be used by the immune system as a template to build up immunity to the virus.

Pages

Alle | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009